{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:47:57Z","timestamp":1788245277890,"version":"build-2803163510"},"reference-count":58,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    Phosphoenolpyruvate carboxykinase (PCK) catalyzes the conversion of oxaloacetate to phosphoenolpyruvate and regulates pyruvate metabolism and gluconeogenesis in response to glucocorticoid and insulin stimuli. Mitochondrial isoform of this enzyme (PCK2) is overexpressed in glioblastoma cells and participates in metabolic reprogramming and cell proliferation. This study aims to examine the impact of ERN1 (endoplasmic reticulum to nucleus signaling 1) inhibition on PCK2 expression and sensitivity to glucose and glutamine deprivation to determine the role of ERN1 signaling in the regulating its expression in glioblastoma cells.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    The glioblastoma cell line U87MG and two genetically modified variants of these cells were used. These were glioblastoma cell sublines with suppressed endoribonuclease and protein kinase activities of ERN1 (dnERN1) or only ERN1 endoribonuclease (dnrERN1), and control cells transfected with an empty vector. The suppression of ERN1 function by silencing of ERN1 and XBP1 mRNAs was also used. Hypoxia was generated using the HIF1A prolyl hydroxylase inhibitor dimethyloxalylglycine. For glucose and glutamine deprivation, DMEM medium without glucose or glutamine was used. The expression level of the PCK2 mRNA was analyzed by real-time qPCR and normalized to the beta-actin mRNA.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    It has been demonstrated that PCK2 mRNA expression is significantly decreased in dnERN1 glioblastoma cells. Similar suppression of this mRNA expression was also observed in cells with only the endoribonuclease activity of ERN1 inhibited, indicating that this enzymatic activity is involved in the regulation of PCK2 expression. The silencing of ERN1 and XBP1 mRNAs also induced similar changes in PCK2 mRNA expression, possibly mediated by XBP1s. The expression of PCK2 was enhanced under glutamine deprivation in control glioblastoma cells, but inhibition of ERN1 activity strongly increased this effect. Upregulated PCK2 expression was also observed in control glioblastoma cells under glucose deprivation. However, the inhibition of ERN1 activity strongly increased the sensitivity of this gene expression to glucose deprivation. Furthermore, PCK2 mRNA expression was resistant to hypoxic conditions in cells with native ERN1. At the same time, in glioblastoma cells with inhibited ERN1 activity, a strong induction of PCK2 expression was observed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    The results of this study demonstrated that ERN1 inhibition reduces PCK2 mRNA expression through the ERN1 endoribonuclease activity. This mRNA expression is upregulated under glutamine and glucose deprivation. Moreover, ERN1 inhibition strongly enhanced the sensitivity of PCK2 mRNA expression to glucose and glutamine deprivation as well as to hypoxia.\n                  <\/jats:p>","DOI":"10.2478\/enr-2026-0008","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:06:12Z","timestamp":1774940772000},"page":"61-71","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of ERN1 suppresses the expression of phosphoenolpyruvate carboxykinase 2 in U87MG glioblastoma cells and increases its sensitivity to glucose and glutamine deprivation"],"prefix":"10.2478","volume":"60","author":[{"given":"Yuliia M.","family":"Viletska","sequence":"first","affiliation":[{"name":"Department of Molecular Biology , Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr H.","family":"Minchenko","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology , Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena O.","family":"Khita","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology , Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslava Y.","family":"Sliusar","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology , Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh V.","family":"Halkin","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology , Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halyna E.","family":"Kozynkevych","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , National Bohomolets Medical University , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro O.","family":"Minchenko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , National Bohomolets Medical University , Kyiv , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026070616023392341_j_enr-2026-0008_ref_001","doi-asserted-by":"crossref","unstructured":"Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD. XBP1 controls diverse cell type- and conditions-specific transcriptional regulatory networks. Molecular Cell 27, 53\u201366, 2007.","DOI":"10.1016\/j.molcel.2007.06.011"},{"key":"2026070616023392341_j_enr-2026-0008_ref_002","doi-asserted-by":"crossref","unstructured":"Acosta-Alvear D, Harnoss JM, Walter P, Ashkenazi A. Homeostasis control in health and disease by the unfolded protein response. Nat Rev Mol Cell Biol 26, 193\u2013212, 2025.","DOI":"10.1038\/s41580-024-00794-0"},{"key":"2026070616023392341_j_enr-2026-0008_ref_003","doi-asserted-by":"crossref","unstructured":"Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S, Papaioannou A, Puschel F, Sassano ML, Skoko J, Agostinis P, de Belleroche J, Eriksson LA, Fulda S, Gorman AM, Healy S, Kozlov A, Munoz-Pinedo C, Rehm M, Chevet E, Samali A. Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J 286, 241\u2013278, 2019.","DOI":"10.1111\/febs.14608"},{"key":"2026070616023392341_j_enr-2026-0008_ref_004","doi-asserted-by":"crossref","unstructured":"Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proc Natl Acad Sci USA 107, 15553\u201315558, 2010.","DOI":"10.1073\/pnas.0914072107"},{"key":"2026070616023392341_j_enr-2026-0008_ref_005","doi-asserted-by":"crossref","unstructured":"Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.","DOI":"10.1186\/1471-2407-13-597"},{"key":"2026070616023392341_j_enr-2026-0008_ref_006","doi-asserted-by":"crossref","unstructured":"Avril T, Vauleon E, Chevet E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis 6, e373, 2017.","DOI":"10.1038\/oncsis.2017.72"},{"key":"2026070616023392341_j_enr-2026-0008_ref_007","unstructured":"Batie M, Rocha S. Gene transcription and chromatin regulation in hypoxia. Biochem Soc Trans 48, 1121\u20131128, 2020."},{"key":"2026070616023392341_j_enr-2026-0008_ref_008","doi-asserted-by":"crossref","unstructured":"Bluemel G, Planque M, Madreiter-Sokolowski CT, Haitzmann T, Hrzenjak A, Graier WF, Fendt SM, Olschewski H, Leithner K. PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells. Free Radic Biol Med 176, 34\u201345, 2021.","DOI":"10.1016\/j.freeradbiomed.2021.09.007"},{"key":"2026070616023392341_j_enr-2026-0008_ref_009","doi-asserted-by":"crossref","unstructured":"Bobarykina AY, Minchenko DO, Opentanova IL, Moenner M, Caro J, Esumi H, Minchenko OH. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim Pol 53, 789\u2013799, 2006.","DOI":"10.18388\/abp.2006_3308"},{"key":"2026070616023392341_j_enr-2026-0008_ref_010","doi-asserted-by":"crossref","unstructured":"Chan MC, Ilott NE, Schodel J, Sims D, Tumber A, Lippl K, Mole DR, Pugh CW, Ratcliffe PJ, Ponting CP, Schofield CJ. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases. J Biol Chem 291, 20661\u201320673, 2016.","DOI":"10.1074\/jbc.M116.749291"},{"key":"2026070616023392341_j_enr-2026-0008_ref_011","doi-asserted-by":"crossref","unstructured":"Chang TM, Fang WY, Hsu HP, Chu PY, Jiang SS, Huang KW, Hung WC, Lin HY, Tsai HJ. PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-beta\/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination. Cancer Biol Ther 26, 2478670, 2025.","DOI":"10.1080\/15384047.2025.2478670"},{"key":"2026070616023392341_j_enr-2026-0008_ref_012","doi-asserted-by":"crossref","unstructured":"Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov 5, 586\u2013597, 2015.","DOI":"10.1158\/2159-8290.CD-14-1490"},{"key":"2026070616023392341_j_enr-2026-0008_ref_013","doi-asserted-by":"crossref","unstructured":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumor. Nat Rev Cancer 8, 705\u2013713, 2008. Doultsinos D, Avril T, Lhomond S, Dejeans N, Guedat P, Chevet E. Control of the unfolded protein response in health and disease. SLAS Discov 22, 787\u2013800, 2017.","DOI":"10.1177\/2472555217701685"},{"key":"2026070616023392341_j_enr-2026-0008_ref_014","doi-asserted-by":"crossref","unstructured":"Flintoaca Alexandru PR, Chiritoiu GN, Lixandru D, Zurac S, Ionescu-Targoviste C, Petrescu SM. EDEM1 regulates the insulin mRNA level by inhibiting the endoplasmic reticulum stress-induced IRE1\/JNK\/c-Jun pathway. iScience 26, 107956, 2023.","DOI":"10.1016\/j.isci.2023.107956"},{"key":"2026070616023392341_j_enr-2026-0008_ref_015","doi-asserted-by":"crossref","unstructured":"Frodyma DE, Troia TC, Rao C, Svoboda RA, Berg JA, Shinde DD, Thomas VC, Lewis RE, Fisher KW. PGC-1beta and ERRalpha promote glutamine metabolism and colorectal cancer survival via transcriptional upregulation of PCK2. Cancers (Basel) 14, 4879, 2022.","DOI":"10.3390\/cancers14194879"},{"key":"2026070616023392341_j_enr-2026-0008_ref_016","doi-asserted-by":"crossref","unstructured":"Gunasekharan V, Lin HK, Marczyk M, Rios-Hoyo A, Campos GE, Shan NL, Ahmed M, Umlauf S, Gareiss P, Raaisa R, Williams R, Cardone R, Siebel S, Kibbey R, Surovtseva YV, Pusztai L. Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer. Breast Cancer Res Treat 208, 657\u2013671, 2024.","DOI":"10.1007\/s10549-024-07462-z"},{"key":"2026070616023392341_j_enr-2026-0008_ref_017","doi-asserted-by":"crossref","unstructured":"He L, Li Y, Zeng N, Stiles BL. Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2. Biochem J 477, 1021\u20131031, 2020.","DOI":"10.1042\/BCJ20190570"},{"key":"2026070616023392341_j_enr-2026-0008_ref_018","doi-asserted-by":"crossref","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21, 421\u2013438, 2020.","DOI":"10.1038\/s41580-020-0250-z"},{"key":"2026070616023392341_j_enr-2026-0008_ref_019","doi-asserted-by":"crossref","unstructured":"Hollien J, Lin JH, Li H, Stevens N, Walter P, Weismann JS. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol 186, 323\u2013331, 2009.","DOI":"10.1083\/jcb.200903014"},{"key":"2026070616023392341_j_enr-2026-0008_ref_020","doi-asserted-by":"crossref","unstructured":"Hwang Y, An HT, Kang M, Ko J. Roles of 14-3-3\u03b2 and \u03b3 in regulation of the glucocorticoid receptor transcriptional activation and hepatic gluconeogenesis. Biochem Biophys Res Commun 501, 800\u2013806, 2018.","DOI":"10.1016\/j.bbrc.2018.05.077"},{"key":"2026070616023392341_j_enr-2026-0008_ref_021","doi-asserted-by":"crossref","unstructured":"Hyrossova P, Arago M, Munoz-Pinedo C, Vinals F, Garcia-Roves PM, Escolano C, Mendez-Lucas A, Perales JC. Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells. Cell Death Dis 13, 730, 2022.","DOI":"10.1038\/s41419-022-05177-x"},{"key":"2026070616023392341_j_enr-2026-0008_ref_022","doi-asserted-by":"crossref","unstructured":"Krasnytska DA, Viletska YM, Minchenko DO, Khita OO, Tsymbal DO, Cherednychenko AA, Kozynkevych HE, Oksiom NS, Minchenko OH. ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 gene expressions in U87 glioma cells. Endocr Regul 57, 37\u201347, 2023.","DOI":"10.2478\/enr-2023-0005"},{"key":"2026070616023392341_j_enr-2026-0008_ref_023","doi-asserted-by":"crossref","unstructured":"Le Reste PJ, Pineau R, Voutetakis K, Samal J, Jegou G, Lhomond S, Gorman AM, Samali A, Patterson JB, Zeng Q, Pandit A, Aubry M, Soriano N, Etcheverry A, Chatziioannou A, Mosser J, Avril T, Chevet E. Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation\/chemotherapy in vivo. Cancer Lett 494, 73\u201383, 2020.","DOI":"10.1016\/j.canlet.2020.08.028"},{"key":"2026070616023392341_j_enr-2026-0008_ref_024","doi-asserted-by":"crossref","unstructured":"Li C, Zhang ED, Ye Y, Xiao Z, Huang H, Zeng Z. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma. Sci Rep 14, 14051, 2024.","DOI":"10.1038\/s41598-024-64907-7"},{"key":"2026070616023392341_j_enr-2026-0008_ref_025","doi-asserted-by":"crossref","unstructured":"Lin J, Wu S, Ye S, Papa APD, Yang J, Huang S, Arthur G, Zhuge Q, Zhang Y. Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by down-regulating PCK2. Phytother Res 35, 2624\u20132638, 2021.","DOI":"10.1002\/ptr.7009"},{"key":"2026070616023392341_j_enr-2026-0008_ref_026","doi-asserted-by":"crossref","unstructured":"Liu Z, Liu G, Ha DP, Wang J, Xiong M, Lee AS. ER chaperone GRP78\/BiP translocates to the nucleus under stress and acts as a transcriptional regulator. Proc Natl Acad Sci U S A 120, e2303448120, 2023.","DOI":"10.1073\/pnas.2303448120"},{"key":"2026070616023392341_j_enr-2026-0008_ref_027","doi-asserted-by":"crossref","unstructured":"Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E, Dwyer RM, Oommen A, Legembre P, Godey F, Madden EC, Leuzzi B, Obacz J, Zeng Q, Patterson JB, Jager R, Gorman AM, Samali A. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 9, 3267, 2018.","DOI":"10.1038\/s41467-018-05763-8"},{"key":"2026070616023392341_j_enr-2026-0008_ref_028","doi-asserted-by":"crossref","unstructured":"Lu X, Huang J, Wu S, Zheng Q, Liu P, Feng H, Su X, Fu H, Xi Q, Wang G. The tRNA-like small noncoding RNA mascRNA promotes global protein translation. EMBO Rep 21, e49684, 2020.","DOI":"10.15252\/embr.201949684"},{"key":"2026070616023392341_j_enr-2026-0008_ref_029","doi-asserted-by":"crossref","unstructured":"Ma X, Gao Y, Liu J, Xu L, Liu W, Huna A, Wang X, Gong W. Low expression of PCK2 in breast tumors contributes to better prognosis by inducing senescence of cancer cells. IUBMB Life 74, 896\u2013907, 2022.","DOI":"10.1002\/iub.2651"},{"key":"2026070616023392341_j_enr-2026-0008_ref_030","doi-asserted-by":"crossref","unstructured":"Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsible element. Mol Cell Biochem 208, 53\u201362, 2000.","DOI":"10.1023\/A:1007042729486"},{"key":"2026070616023392341_j_enr-2026-0008_ref_031","doi-asserted-by":"crossref","unstructured":"Minchenko O, Opentanova I, Minchenko D, Ogura T, Esumi H. Hypoxia induces transcription of 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 4 gene via hypoxia-inducible factor-1alpha activation. FEBS Lett 576, 14\u201320, 2004.","DOI":"10.1016\/j.febslet.2004.08.053"},{"key":"2026070616023392341_j_enr-2026-0008_ref_032","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H. Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells. World J Gastroenterol 20, 13705\u201313717, 2014.","DOI":"10.3748\/wjg.v20.i38.13705"},{"key":"2026070616023392341_j_enr-2026-0008_ref_033","doi-asserted-by":"crossref","unstructured":"Minchenko DO, Riabovol OO, Tsymbal DO, Ratushna OO, Minchenko OH. Inhibition of IRE1 affects the expression of genes encoded glucocorticoid receptor and some related factors and their hypoxic regulation in U87 glioma cells. Endocr Regul 50, 127\u2013136, 2016.","DOI":"10.1515\/enr-2016-0014"},{"key":"2026070616023392341_j_enr-2026-0008_ref_034","doi-asserted-by":"crossref","unstructured":"Minchenko DO, Tsymbal DO, Riabovol OO, Viletska YM, Lahanovska YO, Sliusar MY, Bezrodnyi BH, Minchenko OH. Hypoxic regulation of EDN1, EDNRA, EDNRB, and ECE1 gene expressions in IRE1 knockdown U87 glioma cells. Endocr Regul 53, 250\u2013262, 2019.","DOI":"10.2478\/enr-2019-0025"},{"key":"2026070616023392341_j_enr-2026-0008_ref_035","doi-asserted-by":"crossref","unstructured":"Minchenko DO, Khita OO, Tsymbal DO, Viletska YM, Sliusar MY, Yefimova YV, Levadna LO, Krasnytska DA, Minchenko OH. ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells. Endocr Regul 55, 72\u201382, 2021.","DOI":"10.2478\/enr-2021-0009"},{"key":"2026070616023392341_j_enr-2026-0008_ref_036","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Khita OO, Krasnytska DA, Viletska YM, Rudnytska OV, Hnatiuk OS, Minchenko DO. ERN1 knockdown affects the expression of TGIF1 and other homeobox genes in U87MG glioblastoma cells. Arch Biochem Biophys 758, 110073, 2024a.","DOI":"10.1016\/j.abb.2024.110073"},{"key":"2026070616023392341_j_enr-2026-0008_ref_037","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Sliusar MY, Khikhlo YP, Halkin OV, Viletska YM, Khita OO, Minchenko DO. Knockdown of ERN1 disturbs the expression of phosphoserine aminotransferase 1 and related genes in glioblastoma cells. Arch Biochem Biophys 759, 110104, 2024b.","DOI":"10.1016\/j.abb.2024.110104"},{"key":"2026070616023392341_j_enr-2026-0008_ref_038","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Sliusar MY, Khita OO, Viletska YM, Luzina OY, Danilovskyi SV, Minchenko DO. Endoplasmic reticulum stress-dependent regulation of the expression of serine hydroxymethyltransferase 2 in glioblastoma cells. Endocr Regul 58, 144\u2013152, 2024c.","DOI":"10.2478\/enr-2024-0016"},{"key":"2026070616023392341_j_enr-2026-0008_ref_039","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Sliusar MY, Khita OO, Minchenko DO, Viletska YM, Halkin OV, Ledvadna LO, Cherednychenko AA, Khikhlo YP. Inhibition of signaling protein ERN1 increases the sensitivity of serine synthesis gene expressions to glucose and glutamine deprivations in U87MG glioblastoma cells. Endocr Regul 58, 91\u2013100, 2024d.","DOI":"10.2478\/enr-2024-0010"},{"key":"2026070616023392341_j_enr-2026-0008_ref_040","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Abramchuk AI, Khikhlo YP, Sliusar MY, Halkin OV, Luzina OY, Danilovskyi SV, Viletska YM, Minchenko DO. Hydrocortisone interacts with endoplasmic reticulum stress in hypoxic regulation of phosphoserine aminotransferase 1 gene expression differently in normal human astrocytes and glioblastoma cells. Endocr Regul 59, 48\u201356, 2025a.","DOI":"10.2478\/enr-2025-0007"},{"key":"2026070616023392341_j_enr-2026-0008_ref_041","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Hrebennykova VO, Viletska YM, Hnatiuk OS, Sliusar MY, Kozynkevych HE, Minchenko DO. The ERN1 signaling pathway of unfolded protein response controls the expression of EDEM1 and their hypoxic regulation in glioblastoma cells. Endocr Regul 59, 1\u20139, 2025b.","DOI":"10.2478\/enr-2025-0001"},{"key":"2026070616023392341_j_enr-2026-0008_ref_042","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Viletska YM, Abramchuk AI, Halkin OV, Khikhlo YP, Sliusar MY, Danilovskyi SV, Luzina OY, Minchenko DO. Hypoxic regulation of insulin receptor substrate 2 gene expression is differently regulated by endoplasmic reticulum stress and hydrocortisone in normal human astrocytes and glioblastoma cells. Endocr Regul 59, 171\u2013180, 2025c.","DOI":"10.2478\/enr-2025-0020"},{"key":"2026070616023392341_j_enr-2026-0008_ref_043","doi-asserted-by":"crossref","unstructured":"Minchenko OH, Viletska YM, Sliusar MY, Hnatiuk OS, Ratushna OO, Feldman TV, Kozynkevych HE, Bezrodnyi BH, Minchenko DO. Glucose-dependent control of insulin like growth factor 2 mRNA binding protein 2 and other gene expressions in ERN1 knockdown glioblastoma cells. Endocr Regul 59, 120\u2013129, 2025d.","DOI":"10.2478\/enr-2025-0013"},{"key":"2026070616023392341_j_enr-2026-0008_ref_044","doi-asserted-by":"crossref","unstructured":"Niu L, Chen Q, Hua C, Geng Y, Cai L, Tao S, Ni Y, Zhao R. Effects of chronic dexamethasone administration on hyperglycemia and insulin release in goats. J Anim Sci Biotechnol 9, 26, 2018.","DOI":"10.1186\/s40104-018-0242-4"},{"key":"2026070616023392341_j_enr-2026-0008_ref_045","doi-asserted-by":"crossref","unstructured":"Papaioannou A, Chevet E. Driving cancer tumorigenesis and metastasis through UPR signaling. Curr Top Microbiol Immunol 414, 159\u2013192, 2018.","DOI":"10.1007\/82_2017_36"},{"key":"2026070616023392341_j_enr-2026-0008_ref_046","doi-asserted-by":"crossref","unstructured":"Pelizzari-Raymundo D, Doultsinos D, Pineau R, Sauzay C, Koutsandreas T, Langlais T, Carlesso A, Gkotsi E, Negroni L, Avril T, Chatziioannou A, Chevet E, Eriksson LA, Guillory X. A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. iScience 26, 106687, 2023.","DOI":"10.1016\/j.isci.2023.106687"},{"key":"2026070616023392341_j_enr-2026-0008_ref_047","doi-asserted-by":"crossref","unstructured":"Pelizzari-Raymundo D, Maltret V, Nivet M, Pineau R, Papaioannou A, Zhou X, Caradec F, Martin S, Le Gallo M, Avril T, Chevet E, Lafont E. IRE1 RNase controls CD95-mediated cell death. EMBO Rep 25, 1792\u20131813, 2024.","DOI":"10.15252\/rc.2023949760"},{"key":"2026070616023392341_j_enr-2026-0008_ref_048","doi-asserted-by":"crossref","unstructured":"Riabovol OO, Tsymbal DO, Minchenko DO, Lebid-Biletska KM, Sliusar MY, Rudnytska OV, Minchenko OH. Effect of glucose deprivation on the expression of genes encoding glucocorticoid receptor and some related factors in ERN1-knockdown U87 glioma cells. Endocr Regul 53, 237\u2013249, 2019.","DOI":"10.2478\/enr-2019-0024"},{"key":"2026070616023392341_j_enr-2026-0008_ref_049","doi-asserted-by":"crossref","unstructured":"Semenza GL. A compendium of proteins that interact with HIF-1\u03b1. Exp Cell Res 356, 128\u2013135, 2017.","DOI":"10.1016\/j.yexcr.2017.03.041"},{"key":"2026070616023392341_j_enr-2026-0008_ref_050","doi-asserted-by":"crossref","unstructured":"Sharma R, Kumari M, Prakash P, Gupta S, Tiwari S. Phosphoenolpyruvate carboxykinase in urine exosomes reflect impairment in renal gluconeogenesis in early insulin resistance and diabetes. Am J Physiol Renal Physiol 318, F720\u2013F731, 2020.","DOI":"10.1152\/ajprenal.00507.2019"},{"key":"2026070616023392341_j_enr-2026-0008_ref_051","doi-asserted-by":"crossref","unstructured":"Sliusar MY, Minchenko DO, Khita OO, Tsymbal DO, Viletska YM, Luzina OY, Danilovskyi SV, Ratushna OO, Minchenko OH. Hypoxia controls the expression of genes responsible for serine synthesis in U87MG cells on ERN1-dependent manner. Endocr Regul 57, 252\u2013261, 2023.","DOI":"10.2478\/enr-2023-0028"},{"key":"2026070616023392341_j_enr-2026-0008_ref_052","doi-asserted-by":"crossref","unstructured":"Srinivas V, Leshchinsky I, Sang N, King MP, Minchenko A, Caro J. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem 276, 21995\u201321998, 2001.","DOI":"10.1074\/jbc.C100177200"},{"key":"2026070616023392341_j_enr-2026-0008_ref_053","doi-asserted-by":"crossref","unstructured":"Sun RC, Denko NC. Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab 19, 285\u2013292, 2014.","DOI":"10.1016\/j.cmet.2013.11.022"},{"key":"2026070616023392341_j_enr-2026-0008_ref_054","doi-asserted-by":"crossref","unstructured":"Wang M, Guo FS, Hou DS, Zhang HL, Chen XT, Shen YX, Guo ZF, Zheng ZF, Hu YP, Du PZ, Wang CJ, Lin Y, Yuan YY, Zhao SM, Xu W. Glutamine signaling specifically activates c-Myc and Mcl-1 to facilitate cancer cell proliferation and survival. Protein Cell 16, 968\u2013984, 2025.","DOI":"10.1093\/procel\/pwaf029"},{"key":"2026070616023392341_j_enr-2026-0008_ref_055","doi-asserted-by":"crossref","unstructured":"Xue S, Cai Y, Liu J, Ji K, Yi P, Long H, Zhang X, Li P, Song Y. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. Cell Signal 120, 111198, 2024.","DOI":"10.1016\/j.cellsig.2024.111198"},{"key":"2026070616023392341_j_enr-2026-0008_ref_056","doi-asserted-by":"crossref","unstructured":"Yi L, Jiang C, Guo P, Zhu W, Jiang X. Phosphoenolpyruvate carboxykinase 2 is a promising prognostic biomarker that correlates with peritumoral dendritic cell infiltration in glioblastoma. J Cancer 16, 590\u2013602, 2025.","DOI":"10.7150\/jca.97034"},{"key":"2026070616023392341_j_enr-2026-0008_ref_057","doi-asserted-by":"crossref","unstructured":"Yu S, Meng S, Xiang M, Ma H. Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis. Mol Metab 53, 101257, 2021.","DOI":"10.1016\/j.molmet.2021.101257"},{"key":"2026070616023392341_j_enr-2026-0008_ref_058","doi-asserted-by":"crossref","unstructured":"Zhang Q, Xiao XH, Li M, Li WH, Yu M, Zhang HB, Ping F, Wang ZX, Zheng J. Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats. J Integr Med 12, 162\u2013170, 2014.","DOI":"10.1016\/S2095-4964(14)60020-0"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2026-0008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:12:54Z","timestamp":1783354374000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2026-0008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.2478\/enr-2026-0008"],"URL":"https:\/\/doi.org\/10.2478\/enr-2026-0008","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}